Pavan Bhargava, MD, looks forward to the 2025 Annual Meeting of the American Academy of Neurology, where attendees will learn about the updated diagnostic criteria for relapsing-remitting multiple sclerosis (RRMS), including a new application of MRI techniques that enhances both specificity and sensitivity. Presentations will cover the application of these updated criteria in diverse populations and explore the impact of social determinants of health on MS.
There will also be discussions on biomarkers for diagnosing and predicting outcomes in RRMS, as well as updates on new treatments. Experts will also provide insights into the role of diet in managing MS and improving patient outcomes.
Any views expressed above are the author's own and do not necessarily reflect the views of WebMD or Medscape.
